• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

弥散张量成像优于脑脊液,可预测主观认知障碍和轻度认知障碍患者认知下降和内侧颞叶萎缩。

Diffusion tensor imaging surpasses cerebrospinal fluid as predictor of cognitive decline and medial temporal lobe atrophy in subjective cognitive impairment and mild cognitive impairment.

机构信息

Department of Neurology, Faculty Division, Akershus University Hospital, University of Oslo, Lørenskog, Norway.

出版信息

J Alzheimers Dis. 2013;33(3):723-36. doi: 10.3233/JAD-2012-121603.

DOI:10.3233/JAD-2012-121603
PMID:23186987
Abstract

Neuropathological correlates of Alzheimer's disease (AD) emerge years before dementia. Biomarkers preceding cognitive decline and reflecting the causative processes can potentially aid early intervention and diagnosis. Diffusion tensor imaging (DTI) indirectly reflects tissue microstructure. To answer whether DTI is an early biomarker for AD and to explore the relationship between DTI and the established biomarkers of medial temporal lobe atrophy and cerebrospinal fluid (CSF) Aβ(42), T-tau, and P-tau, we longitudinally studied normal controls and patients with subjective (SCI) or mild (MCI) cognitive impairment. 21 controls and 64 SCI or MCI cases recruited from a university-hospital based memory clinic were re-examined after two to three years. FreeSurfer was used for longitudinal processing of morphometric data, and DTI derived fractional anisotropy, radial diffusivity, and mean diffusivity were analyzed in Tract-Based Spatial Statistics. Using regression models, we explored and compared the predictive powers of DTI and CSF biomarkers in regard to cognitive change and atrophy of the medial temporal lobe. Both DTI and CSF biomarkers significantly predicted cognitive decline and atrophy in the medial temporal lobe. In this population, however, DTI was a better predictor of dementia and AD-specific medial temporal lobe atrophy than the CSF biomarkers. The case for DTI as an early biomarker for AD is strengthened, but further studies are needed to confirm these results.

摘要

阿尔茨海默病(AD)的神经病理学表现早在痴呆症出现多年前就已出现。能够反映致病过程并预示认知能力下降的生物标志物,可能有助于早期干预和诊断。弥散张量成像(DTI)间接反映组织的微观结构。为了回答 DTI 是否为 AD 的早期生物标志物,并探讨 DTI 与内侧颞叶萎缩和脑脊液(CSF)中 Aβ(42)、Tau 蛋白和 P-Tau 等已确立的生物标志物之间的关系,我们对正常对照者和有主观认知障碍(SCI)或轻度认知障碍(MCI)的患者进行了纵向研究。我们从一所大学医院的记忆诊所招募了 21 名正常对照者和 64 名 SCI 或 MCI 患者,对他们进行了为期 2 到 3 年的随访。使用 FreeSurfer 对形态计量数据进行纵向处理,并在基于束的空间统计中分析 DTI 得出的各向异性分数、放射状弥散度和平均弥散度。我们使用回归模型,探索和比较了 DTI 和 CSF 生物标志物在认知变化和内侧颞叶萎缩方面的预测能力。DTI 和 CSF 生物标志物均显著预测了认知能力下降和内侧颞叶萎缩。然而,在该人群中,与 CSF 生物标志物相比,DTI 是痴呆症和 AD 特异性内侧颞叶萎缩的更好预测指标。DTI 作为 AD 早期生物标志物的说法得到了加强,但需要进一步的研究来证实这些结果。

相似文献

1
Diffusion tensor imaging surpasses cerebrospinal fluid as predictor of cognitive decline and medial temporal lobe atrophy in subjective cognitive impairment and mild cognitive impairment.弥散张量成像优于脑脊液,可预测主观认知障碍和轻度认知障碍患者认知下降和内侧颞叶萎缩。
J Alzheimers Dis. 2013;33(3):723-36. doi: 10.3233/JAD-2012-121603.
2
The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease.阿尔茨海默病患者脑脊液生物标志物与大脑结构变化的关系。
J Intern Med. 2014 Apr;275(4):418-27. doi: 10.1111/joim.12164. Epub 2013 Dec 11.
3
Progression to dementia in memory clinic patients with mild cognitive impairment and normal β-amyloid.记忆门诊中伴有正常β-淀粉样蛋白的轻度认知障碍患者向痴呆的进展。
Alzheimers Res Ther. 2019 Dec 5;11(1):99. doi: 10.1186/s13195-019-0557-1.
4
Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.在一个早期富集的轻度认知障碍样本中,用于预测转化和认知衰退的认知标志物和生物标志物的不同强度。
J Alzheimers Dis. 2015;44(2):625-33. doi: 10.3233/JAD-141716.
5
Progressive medial temporal lobe atrophy during preclinical Alzheimer's disease.在临床前阿尔茨海默病期间进行性内侧颞叶萎缩。
Neuroimage Clin. 2017 Aug 25;16:439-446. doi: 10.1016/j.nicl.2017.08.022. eCollection 2017.
6
Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.从阿尔茨海默病临床前期到痴呆阶段的认知、脑萎缩和脑脊液生物标志物变化以及载脂蛋白E的影响
J Alzheimers Dis. 2015;45(1):253-68. doi: 10.3233/JAD-142451.
7
New MRI markers for Alzheimer's disease: a meta-analysis of diffusion tensor imaging and a comparison with medial temporal lobe measurements.阿尔茨海默病的新 MRI 标志物:弥散张量成像的荟萃分析及与内侧颞叶测量的比较。
J Alzheimers Dis. 2012;29(2):405-29. doi: 10.3233/JAD-2011-110797.
8
T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease.T1rho磁共振成像与脑脊液生物标志物在阿尔茨海默病诊断中的应用
Neuroimage Clin. 2015 Feb 26;7:598-604. doi: 10.1016/j.nicl.2015.02.016. eCollection 2015.
9
Cerebrospinal Fluid C-C Motif Chemokine Ligand 2 Correlates with Brain Atrophy and Cognitive Impairment in Alzheimer's Disease.脑脊髓液 C-C 基序趋化因子配体 2 与阿尔茨海默病的脑萎缩和认知障碍相关。
J Alzheimers Dis. 2018;61(2):581-588. doi: 10.3233/JAD-170519.
10
Cerebrospinal Fluid Biomarkers and Clinical Progression in Patients with Subjective Cognitive Decline and Mild Cognitive Impairment.主观认知下降和轻度认知障碍患者的脑脊液生物标志物与临床进展
J Alzheimers Dis. 2017;58(3):939-950. doi: 10.3233/JAD-161252.

引用本文的文献

1
Alzheimer's disease neuropathology and longitudinal change in subjective cognitive complaints.阿尔茨海默病神经病理学与主观认知主诉的纵向变化
Alzheimers Dement (Amst). 2025 Aug 28;17(3):e70176. doi: 10.1002/dad2.70176. eCollection 2025 Jul-Sep.
2
Supraspan memory performance is impaired in subjective cognitive impairment compared to cognitively unimpaired individuals.与认知未受损个体相比,主观认知障碍患者的超跨度记忆表现受损。
Sci Rep. 2025 Jul 2;15(1):23071. doi: 10.1038/s41598-025-07664-5.
3
Diffusion imaging markers of accelerated aging of the lower cingulum in subjective cognitive decline.
主观认知衰退中扣带回下部加速老化的扩散成像标志物
Front Neurol. 2024 May 9;15:1360273. doi: 10.3389/fneur.2024.1360273. eCollection 2024.
4
Comparative analysis of multimodal biomarkers for amyloid-beta positivity detection in Alzheimer's disease cohorts.阿尔茨海默病队列中用于检测β淀粉样蛋白阳性的多模态生物标志物的比较分析。
Front Aging Neurosci. 2024 Feb 26;16:1345417. doi: 10.3389/fnagi.2024.1345417. eCollection 2024.
5
Diffusion Tensor Imaging in Alzheimer's Studies.弥散张量成像在阿尔茨海默病研究中的应用。
Methods Mol Biol. 2024;2785:105-113. doi: 10.1007/978-1-0716-3774-6_8.
6
Circulating polyunsaturated fatty acids, fish oil supplementation, and risk of incident dementia: a prospective cohort study of 440,750 participants.循环多不饱和脂肪酸、鱼油补充剂与新发痴呆风险:一项对 440750 名参与者的前瞻性队列研究。
Geroscience. 2023 Jun;45(3):1997-2009. doi: 10.1007/s11357-023-00778-6. Epub 2023 Apr 12.
7
Joint independent component analysis for hypothesizing spatiotemporal relationships between longitudinal gray and white matter changes in preclinical Alzheimer's disease.联合独立成分分析用于推测临床前阿尔茨海默病中纵向灰质和白质变化之间的时空关系。
Proc SPIE Int Soc Opt Eng. 2022 Feb-Mar;12032. doi: 10.1117/12.2611562. Epub 2022 Apr 4.
8
The relationship between white matter microstructure and self-perceived cognitive decline.脑白质微观结构与自我感知认知衰退的关系。
Neuroimage Clin. 2021;32:102794. doi: 10.1016/j.nicl.2021.102794. Epub 2021 Aug 28.
9
The interplay between gray matter and white matter neurodegeneration in subjective cognitive decline.主观认知下降中灰质和白质神经退行性变的相互作用。
Aging (Albany NY). 2021 Aug 25;13(16):19963-19977. doi: 10.18632/aging.203467.
10
Combined Support Vector Machine Classifier and Brain Structural Network Features for the Individual Classification of Amnestic Mild Cognitive Impairment and Subjective Cognitive Decline Patients.结合支持向量机分类器和脑结构网络特征用于遗忘型轻度认知障碍和主观认知衰退患者的个体分类
Front Aging Neurosci. 2021 Jul 30;13:687927. doi: 10.3389/fnagi.2021.687927. eCollection 2021.